BioNTech says it will release more data on possible vaccine redesign

241
1
BioNTech says it will release more data on possible vaccine redesign

Is there any indication that a vaccine redesign is warranted?

BioNTech, Pfizer, in order to establish a relaunch routine adds details on redesign strategy FRANKFURT, Nov 26, Reuters -- BioNTech said it expects more laboratory data on a new worrying coronavirus variant detected in South Africa within two weeks to determine whether the biotech firm's shot would have to be reworked.

We understand the concerns of experts and have immediately initiated investigations on variant B. When asked to comment, the company, 529, said it was in a vaccine alliance with Pfizer.

More data from laboratory tests is expected to be released in two weeks at the latest. These data will provide more information about whether or not B. It added that 529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally.

Escape variants are viruses that elude the immune response brought about by vaccination.

BioNTech said that Pfizer and BioNTech would be able to redesign their shot within 6 weeks and ship initial batches within 100 days.

With the EU and Britain tightening border controls as scientists tried to find out if the mutation was vaccine-resistant, global authorities reacted with alarm on Friday.